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Abstract
Early life exposure to endocrine disrupting chemicals may alter adipogenesis and energy balance 
leading to changes in obesity risk. Several studies have evaluated the association of prenatal 
bisphenol A exposure with childhood body size but only one study of male infants has examined 
other environmental phenols. Therefore, we assessed associations between prenatal exposure to 
environmental phenols and fat mass in a prospective birth cohort. We quantified four phenol 
biomarkers in third trimester maternal spot urine samples in a cohort of women enrolled in New 
York City between 1998 and 2002 and evaluated fat mass in their children using a Tanita scale 
between ages 4 and 9 years (173 children with 351 total observations). We estimated associations 
of standard deviation differences in natural log creatinine-standardized phenol biomarker 
concentrations with percent fat mass using linear mixed effects regression models. We did not 
observe associations of bisphenol A or triclosan with childhood percent fat mass. In unadjusted 
models, maternal urinary concentrations of 2,5-dichlorophenol were associated with greater 
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percent fat mass and benzophenone-3 was associated with lower percent fat mass among children. 
After adjustment, phenol biomarkers were not associated with percent fat mass. However, the 
association between benzophenone-3 and percent fat mass was modified by child’s sex: 
benzophenone-3 concentrations were inversely associated with percent fat mass in girls (beta = 
−1.51, 95% CI = −3.06, 0.01) but not boys (beta = −0.20, 95% CI = −1.69, 1.26). Although we did 
not observe strong evidence that prenatal environmental phenols exposures influence the 
development of childhood adiposity, the potential antiadipogenic effect of benzophenone-3 in girls 
may warrant further investigation.
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Phenols; Pediatric Obesity; Endocrine Disruptors; Environmental Exposure
1. Introduction
Environmental phenols are high-production-volume chemicals used in a variety of common 
consumer products. Population-based biomonitoring surveys report ubiquitous exposure to 
these chemicals in the United States (Centers for Disease Control and Prevention 2015) and 
widespread exposures have also been observed in other industrialized countries (Engel and 
others 2014; Guidry and others 2015; Heffernan and others 2015; Moos and others 2014). 
Bisphenol A is an endocrine disrupting chemical used in the manufacture of polycarbonate 
plastics and resins found in the linings of cans and bottles, among other products (Rubin 
2011). Other phenolic compounds, including benzophenone-3, 2,5- dichlorophenol, and 
triclosan, may also have endocrine disrupting properties (Kim and Choi 2014; Takahashi and 
others 2007; Wang and Tian 2015). Benzophenone-3 is an ultraviolet filter used in sunscreen 
and cosmetics; 2,5-dichlorophenol is a metabolite of 1,4-dichlorobenzene, a chemical used 
in mothballs, deodorizers, and fumigants; and triclosan is a microbicide used in antibacterial 
soaps and other personal care products.
Endocrine disrupting chemicals, including phenols, are hypothesized to be “environmental 
obesogens” due to their capacity to perturb biological processes regulated by the endocrine 
system including hormonal or nuclear receptor-signaling mechanisms related to fat 
accumulation (Grun and Blumberg 2009; Janesick and Blumberg 2011). The chemical 
structures of phenolic compounds resemble those of known thyroid agonists or 
antiobesogens (Wolff and others 2015), suggesting that phenols may have varied potential to 
interfere with processes related to obesity. The prenatal period may be an important critical 
window for altered developmental programming of adipogenesis and metabolic homeostasis 
(Newbold and others 2009). In human prospective studies, associations of gestational 
exposure to bisphenol A with childhood body size have been inconsistent, with studies 
reporting positive (Valvi and others 2013), inverse (girls only) (Harley and others 2013), and 
null (Agay-Shay and others 2015; Braun and others 2014; Philippat and others 2014) 
associations. The only prospective study of prenatal exposure to other environmental 
phenols assessed early postnatal growth in a cohort of male infants (Philippat and others 
2014) and thus could not estimate associations among females or evaluate the potential for 
sex-specific effects.
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Obesity is a leading cause of childhood illness that is associated with numerous 
comorbidities including diabetes, metabolic syndrome, depression, and asthma (Daniels and 
others 2005). Obese children are at increased risk of becoming obese adults (Freedman and 
others 2005), with the associated increased risk of chronic health conditions such as 
cardiovascular disease and cancer. Understanding the potential contribution of 
environmental chemicals to the obesity epidemic is of importance given the rapid rise in 
childhood obesity prevalence in the United States (Ogden and Carroll 2010) and worldwide 
(de Onis and others 2010). The objective of this study was to evaluate the hypothesis that 
prenatal exposures to environmental phenols are associated with altered body fat among 
children. Therefore, we estimated associations of environmental phenols with percent fat 
mass among children aged 4 to 9 years in a New York City prospective birth cohort.
2. Methods
2.1. Study design and sample population
The Mount Sinai Children’s Environmental Health Study is a longitudinal birth cohort that 
enrolled 479 primiparous women with singleton pregnancies in New York City. Women 
were enrolled from the Mount Sinai Diagnostic and Treatment Center and two adjacent 
private practices between 1998 and 2002. After exclusion of 75 women for reasons 
described previously (Engel and others 2007), the final cohort consists of 404 healthy 
women and infants. At approximately ages 4-5.5 (mean=4.9), 6 (mean=6.2), and 7-9 
(mean=7.8) years, children were invited to return for a follow-up visit (hereafter referred to 
as visit 1, 2, and 3, respectively). We obtained informed consent from women prior to 
participation (children aged ≥7 years provided assent). The Mount Sinai School of Medicine 
Institutional Review Board approved the study; the current analysis was approved by the 
University of North Carolina at Chapel Hill Institutional Review Board. The involvement of 
the Centers for Disease Control and Prevention (CDC) laboratory was determined not to 
constitute engagement in human subjects research.
Phenol biomarkers data were available for 367 of the 404 infants in the birth cohort. We 
excluded one observation with a urinary creatinine concentration <10 mg/dL following 
previous work in this cohort suggesting biomarkers obtained from extremely dilute urine 
samples may be inaccurate (Wolff and others 2008). The current analysis therefore includes 
173 children with at least one fat mass measurement between the ages of 4 and 9 years (total 
number of observations = 351).
2.2. Data collection
Covariate data were collected via a two hour structured interview at enrollment, a perinatal 
database at Mount Sinai Hospital, and questionnaires administered to caretakers at follow-
up. Following the approach of Bodnar et al. (Bodnar and others 2011), we used first and last 
pregnancy weights to calculate adequacy of gestational weight gain based on the 2009 
Institute of Medicine recommendations (Institute of Medicine and National Research 
Council Committee to Reexamine Institute of Medicine Pregnancy Weight Guidelines 
2009). We dichotomized physical activity at each follow-up visit as active if the parent/
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caretaker reported the child was “active most of the time” or as inactive if the parent/
caretaker reported the child was “active some of the time” or “hardly at all”.
Trained research staff obtained body measurements at each follow-up visit from children in 
bare or stocking feet wearing a pediatric gown or light clothing. Bioelectrical impedance 
analysis was performed using a pediatric Tanita scale calibrated for use in children aged 7 
years and older (model TBF-300; Tanita Corporation of America). We used the scale-
estimated fat mass values to calculate percent fat mass [(fat mass / weight) × 100]. We 
calculated BMI as weight (kg) /height (m)2, used a CDC SAS macro to determine age- and 
sex-standardized BMI percentiles, and classified children ≥85th percentile as overweight or 
obese (CDC 2004).
Bisphenol A, benzophenone-3, 2,5-dichlorophenol, triclosan, di-(2-ethylhexyl) phthalate 
(DEHP) metabolites, and creatinine were measured in third trimester (mean=31.5 weeks, 
range=25-40 weeks) maternal spot urine samples at CDC using previously reported 
laboratory and quality control methods (Kato and others 2005; Ye and others 2005). DEHP 
metabolites measured included mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-
hydroxyhexyl) phthalate, mono(2-ethyl-5-oxohexyl) phthalate, and mono(2-ethyl-5-
carboxypentyl) phthalate.
2.3. Statistical analysis
We used a Bayesian modeling framework to estimate associations of prenatal phenol 
biomarker concentrations with percent fat mass while addressing multiple potential biases, 
including accounting for biomarker concentrations below the limits of detection, imputing 
missing covariate data, and assessing potential bias from loss to follow-up.
2.3.1. Concentrations below the limits of detection—We accounted for biomarker 
concentrations below the limits of detection by imputing values from a truncated normal 
distribution (Carmichael and others 2010; Uh and others 2008) within the Markov chain 
Monte Carlo (MCMC) algorithm using the WinBUGS package djl.dnorm.trunc (Lunn 
2003). Parameters were defined as the mean and standard deviation of the observed 
biomarker distribution, a minimum of zero, and a maximum of the limits of detection. To 
compare estimated relative effect sizes on a common scale, we standardized the distribution 
of each biomarker to its mean and standard deviation (SD) in the study population. We 
specified an independent normal prior distribution for phenol beta coefficients with a mean 
of zero and variance of 64. This variance represents a conservative prior belief that 95% of 
the effects of a SD increase in natural log phenol biomarker concentration are within ± one 
SD of the mean percent fat mass in the study population.
2.3.2. Urinary dilution—We modeled phenol biomarker concentrations accounting for 
urinary dilution using a Bayesian modification of the covariate-adjusted creatinine 
standardization approach described by O’Brien et al. (O'Brien and others 2015). We 
modeled natural log creatinine as a random normal variable conditional on the following 
known predictors of creatinine concentrations that were associated with creatinine in our 
study population: maternal age, race/ethnicity, education, pre-pregnancy BMI, and height. 
At each iteration of the MCMC algorithm, we divided the phenol biomarker concentration 
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by the ratio of the participant’s observed creatinine concentration to her predicted 
concentration and used the natural log of this value as the unit of exposure. As 
recommended by O’Brien et al., we also included natural log creatinine in models to adjust 
for residual confounding by urinary dilution.
2.3.3. Covariate adjustment—We used directed acyclic graphs to identify 1) potential 
confounders of associations between phenol biomarker concentrations and percent fat mass, 
and 2) predictors of childhood adiposity that are not on the causal pathway of interest. We 
adjusted for maternal sociodemographic characteristics including race/ethnicity (non-
Hispanic white/non-Hispanic black/Hispanic), age (cubic), education (≥college degree/
<college degree), and work status during pregnancy (employed/student or homemaker). We 
adjusted for strong correlates of childhood adiposity that may also be associated with phenol 
exposures, including pre-pregnancy maternal BMI (quadratic), adequacy of maternal 
gestational weight gain (cubic), and maternal smoking during pregnancy (yes/no) (Weng and 
others 2012). We adjusted for calendar date of urine collection (linear) to account for 
unmeasured factors that drive population time trends in both phenols exposures and 
childhood obesity prevalence (such as dietary patterns). Because we previously reported an 
inverse association of DEHP with percent fat mass in this cohort (Buckley and others 2015), 
and DEHP and phenols may have common sources, we adjusted for summed DEHP 
metabolite concentrations as a potential confounder. To improve precision of our estimates, 
we included predictors of childhood body size including maternal height (linear), child’s sex 
(male/female), breastfeeding (ever/never), age at follow-up (months), and physical activity 
(active/inactive). We additionally included product terms between child’s sex and maternal 
smoking during pregnancy and between child’s sex and months of age at follow-up because 
associations of smoking and age with percent fat mass differed substantially by child’s sex. 
To put beta coefficients for continuous and binary covariates on a common scale, we 
standardized continuous covariates to twice their SD in the study population (Gelman and 
others 2013).
Within our Bayesian framework, we multiply imputed missing values for adequacy of 
gestational weight gain (n = 19), breastfeeding (n = 1), and physical activity at follow-up (n 
= 3 children with 8 visits) assuming data were missing at random. We specified parametric 
models for each variable, conditional on covariates as described previously (Buckley and 
others 2015).
2.3.4. Effect estimation—We modeled adjusted associations between SD increases in 
natural log creatinine-standardized phenol biomarker concentrations and percent fat mass 
using linear mixed effects regression models with random intercepts to account for repeated 
outcome measurements. For the residual and random effects variances, we specified uniform 
prior distributions on the standard deviation with bounds of 0 and 16. We estimated posterior 
mean beta coefficients and 95% credible intervals (CIs), calculated as the 2.5th and 97.5th 
percentiles of the posterior distributions. To examine effect measure modification of 
associations by child’s sex, we included product terms between sex and each phenol 
biomarker. Using a metric analogous to an alpha level of 0.2 in a frequentist analysis, we 
considered there to be effect measure modification if the 80% CI for the interaction term did 
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not cross the null value. We also assessed effect measure modification of benzophenone-3 
associations with percent fat mass by maternal race/ethnicity because exposure to 
benzophenone-3 is predominantly through application of sunscreen, which may differ by 
race/ethnicity. We examined deviations from log-linear exposure-response relationships by 
fitting models with indicator variables for the second and third tertile of creatinine-
standardized concentrations of each phenol biomarker.
2.3.5. Sensitivity analyses—To explore whether associations of phenol biomarkers with 
percent fat mass differed by age at follow-up, we estimated associations among children 
attending each of the three follow-up visits in stratified models using linear regression.
We conducted sensitivity analyses that implemented alternative approaches for creatinine 
normalization to facilitate comparisons with other studies and evaluate the performance of 
the O’Brien et al. method to account for urinary dilution. We compared the estimated 
associations from our primary adjusted model, which used creatinine-standardized 
concentrations and adjusted for natural log creatinine, to estimates using four other 
approaches: 1) modeling natural log phenol biomarker concentrations without accounting 
for urinary dilution, 2) modeling natural log phenol biomarker concentrations with 
adjustment for natural log creatinine as a covariate, 3) modeling natural log creatinine-
corrected phenol biomarker concentrations (micrograms per gram creatinine), and 4) 
modeling natural log creatinine-standardized phenol biomarker concentrations, as in the 
primary analysis, but without additional adjustment for natural log creatinine.
We previously reported that the probability of a missing childhood fat mass measurement 
may depend on its true value (i.e., missing not at random), with evidence that children with 
greater fat mass were more likely to be observed at follow-up in this cohort (Buckley and 
others 2015). Therefore, we conducted a sensitivity analysis to assess whether loss to follow-
up biased our associations between prenatal phenol biomarker concentrations and percent fat 
mass. Our primary models included children with at least one follow-up visit (N=173) and 
assumed outcomes were missing at random. We compared results from our primary models 
to those from a selection model approach to estimate associations among all 360 children 
with measured prenatal phenol biomarker concentrations (Little and Rubin 2002). We have 
previously described the details of this model (Buckley and others 2015). Briefly, we created 
a binary missing outcome indicator variable for visit attendance. We jointly fit the outcome 
model with a logistic mixed effects model with random intercepts for the missing outcome 
indicator variable, conditional on percent fat mass as well as variables associated with loss to 
follow-up including maternal age at delivery, race/ethnicity, pre-pregnancy BMI, adequacy 
of gestational weight gain, child’s sex, and months of age at follow-up. For the random 
effects variance, we specified a uniform prior distribution on the standard deviation with 
bounds of 0 and 10.
2.3.6. Software—We used SAS version 9.3 (SAS Institute, Cary, North Carolina) to 
generate descriptive statistics and assess group differences in natural log creatinine-corrected 
phenol biomarker concentrations using Wilcoxon signed rank sum tests. For Bayesian 
analyses, we used WinBUGS version 1.4.3 (MRC Biostatistics Unit, Cambridge, UK). After 
a 10,000 iteration burn-in, we ran our final Bayesian models for 50,000 iterations and 
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assessed model convergence using standard diagnostics (Gelman and others 2013). For the 
sensitivity analysis for loss to follow-up, we ran ten chains for inference from the MCMC 
procedure.
3. Results
Maternal characteristics of the study sample were similar to those of the entire birth cohort 
(Table 1), with a majority of mothers being Hispanic, less than 25 years old at delivery, and 
employed during pregnancy. Although most mothers had a normal pre-pregnancy BMI, 
nearly two-thirds gained more weight during gestation than recommended by the Institute of 
Medicine. We detected environmental phenol biomarker concentrations in 80% (triclosan) to 
100% (2,5-dichlorophenol) of women (Table 2) and distributions in the follow-up sample 
were similar to those previously reported in the full cohort (Wolff and others 2008). 
Geometric mean concentrations of 2,5-dichlorophenol and triclosan were higher and 
bisphenol A and benzophenone-3 were lower than among female participants in the 
2003-2004 U.S. National Health and Nutrition Examination Survey (Table 2). Forty percent 
(n = 70) of the children were classified as overweight or obese during at least one follow-up 
visit. Percent fat mass increased with age and differed by sex with boys having greater 
percent fat mass, particularly at younger ages (Table 3).
Unadjusted and adjusted associations of third trimester maternal urinary phenol biomarker 
concentrations with percent fat mass are reported in Table 4. In unadjusted analyses, 
associations of phenol biomarker concentrations with percent fat mass were positive for 2,5-
dichlorophenol, inverse for benzophenone-3, and null for bisphenol A and triclosan. After 
adjustment, none of the phenol biomarkers were associated with percent fat mass in the 
overall sample. The benzophenone-3 association was modified by child’s sex, with lower 
percent fat mass in girls (β per SD = −1.51, 95% CI = −3.06, 0.01) and no association among 
boys (β per SD = −0.20, 95% CI = −1.69, 1.26). Assessment of tertiles of phenol biomarker 
exposures were consistent with generally null adjusted associations and did not suggest 
deviations from log-linear exposure response relationships (see Supplemental Table S1).
Third trimester maternal urinary benzophenone-3 concentrations were significantly lower 
among children of mothers who self-identified as non-Hispanic black (median=1.59 μg/g-
creatinine) than among children of Hispanic (median=2.16 μg/g-creatinine) or non-Hispanic 
white (median=3.31 μg/g-creatinine) mothers (p=0.01 and p<0.001, respectively). However, 
associations between benzophenone-3 concentration and percent fat mass were similar 
among children of non-Hispanic black (β per SD = −1.10, 95% CI = −3.63, 1.42), Hispanic 
(β per SD = −0.84, 95% CI = −2.24, 0.55), and non-Hispanic white (β per SD = −0.52, 95% 
CI = −2.94, 1.88) mothers.
In sensitivity analyses, we observed positive associations between 2,5-dichlorophenol and 
bisphenol A and percent fat mass at the earliest follow-up visit (age 4-5.5 years) but 
associations did not persist at older ages (see Supplemental Table S2). However, our sample 
size at each visit was limited and estimates were imprecise.
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Associations between prenatal phenol biomarkers and percent fat mass were similar using 
different methods to account for creatinine concentrations as a measure of urinary dilution 
(see Supplemental Table S3). All methods of creatinine normalization resulted in estimates 
that were closer to the null than estimates from models that did not account for urinary 
dilution, with the exception of estimates for benzophenone-3 where all methods resulted in 
estimates further from the null. Estimated associations using both creatinine-standardization 
approaches (with and without additional adjustment for natural log creatinine) were more 
precise than estimates using the other approaches.
Our sensitivity analysis for bias due to loss to follow-up did not alter conclusions regarding 
associations between third trimester maternal urinary phenol biomarker concentrations and 
percent fat mass (see Supplemental Table S4).
4. Discussion and conclusions
In the overall population, third trimester maternal urinary concentrations of four 
environmental phenol biomarkers were not associated with increased adiposity among 
children aged 4 to 9 years. We observed modification of the association between 
benzophenone-3 and percent fat mass by child’s sex, with lower percent fat mass among 
girls and no association among boys. Consistent with this finding, we previously reported a 
similar sexually-dimorphic association of prenatal benzophenone-3 exposure and birth 
weight in this cohort, where benzophenone-3 concentrations in the highest compared to 
lowest concentration tertile were associated with lower birth weight in girls but higher birth 
weight in boys (Wolff and others 2008). Although these results suggest that benzophenone-3 
may interfere with fat development, no other studies have prospectively assessed the 
relationship between prenatal benzophenone-3 exposure and body size in girls and the 
mechanisms for a sex-specific antiadipogenic effect of benzophenone-3 have not been 
established.
The only other study of prenatal benzophenone-3 exposure and child body size examined 
second trimester maternal urinary benzophenone-3 concentrations among boys in the French 
EDEN cohort (Philippat and others 2014). Similar to our findings for boys, benzophenone-3 
was not associated with weight, length, or abdominal circumference measured at birth 
through 3 years of age. This study did not include female offspring and therefore could not 
examine differences in association by child’s sex. In a multi-site prospective study of girls, 
Wolff and others observed an association between childhood benzophenone-3 concentrations 
and delayed puberty (Wolff and others 2015). The authors hypothesized that this association 
may be mediated by antiadipogenic activity of benzophenone-3 given that its chemical 
structure is similar to that of antiobesogenic chemicals such as adiporon (Okada-Iwabu and 
others 2013). Although sensitivity analyses did not suggest that body mass index mediated 
the effect of benzophenone-3 on puberty (Wolff and others 2015), benzophenone-3 
concentrations were measured at age 6 to 8 years rather than prenatally as in the current 
study. Animal literature examining the potential mechanistic targets of benzophenone-3 is 
lacking, though benzophenone-3 has been reported to have antiandrogenic as well as weak 
estrogenic and antiestrogenic activity in vivo and in vitro (Kim and Choi 2014). To our 
knowledge, no experimental studies have directly assessed the influence of early life 
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exposure to benzophenone-3 on subsequent body fatness in animals. However, female adult 
ovariectomized rats exposed for three months to benzophenone-2, a structural analog of 
benzophenone-3, exhibited dose-dependent reductions in body weight gain, paratibial fat 
depot size, and serum leptin levels compared to controls (Seidlova-Wuttke and others 2005).
Bisphenol A is a suspected environmental obesogen and early life exposure has been 
reported to increase body weight and abdominal fat in animals (Grun and Blumberg 2009; 
Janesick and Blumberg 2011). However, not all studies observed increased body size 
associated with bisphenol A exposure, studies report differences in the direction of sex-
specific effects, and controversy exists surrounding the evaluation of low-dose effects (Vom 
Saal and others 2012). Similar to the current analysis, most prospective epidemiologic 
studies of gestational bisphenol A exposure and childhood body size have reported null 
associations (Agay-Shay and others 2015; Braun and others 2014; Philippat and others 
2014), though positive (Valvi and others 2013) and inverse (girls only) (Harley and others 
2013) associations have also been reported. Several factors could explain differences 
between studies, including timing and number of biomarker measurements, age at outcome 
assessment, distributions of unmeasured confounders or effect modifiers, and underlying 
differences in population susceptibility. In the Spanish INMA cohort, Valvi et al. reported 
weak positive association of prenatal bisphenol A exposure with waist circumference and 
BMI z-scores at age 4 years (Valvi and others 2013). However, a subsequent study following 
children in this cohort until age 7 years found no association of prenatal bisphenol A with 
body size (Agay-Shay and others 2015). Harley et al. reported inverse associations of 
prenatal bisphenol A exposure with percent body fat, BMI z-scores, and risk of obesity 
among girls (but not boys) at age 9 years but no associations were observed at age 5 (Harley 
and others 2013). Because Harley et al. assessed associations among the oldest children 
studied to date, it is possible that effects of bisphenol A manifest later, for example due to 
puberty-related changes in body composition. However, Harley et al. reported stronger 
associations among girls who had not yet reached puberty (Harley and others 2013).
After adjustment, prenatal urinary biomarkers of 2,5-dichlorophenol and triclosan were not 
associated with childhood fat mass. Cross-sectional studies have reported relationships 
between 2,5-dichlorophenol and triclosan with body size outcomes (Buser and others 2014; 
Lankester and others 2013; Li and others 2015; Wei and others 2014). However, cross-
sectional studies that measure concurrent exposures and outcomes cannot establish causality 
(Engel and Wolff 2013) and it is possible that exposures to these chemicals or their 
precurcors may be influenced by factors associated with body size, rather than vice versa. It 
is also difficult to compare findings given that these studies evaluated exposure among 
children or adults whereas the current study evaluated prenatal exposures. In the only other 
study to assess prenatal exposures, second trimester 2,5-dichlorophenol and triclosan were 
not related to body size parameters assessed between the ages of 6 months and 3 years in a 
cohort of French boys (Philippat and others 2014).
Our use of a single, third trimester spot urine sample to represent environmental phenol 
exposures is an important limitation of this study given that these chemicals are quickly 
metabolized and excreted in urine, and exposures are likely episodic in nature. Studies of 
repeat urinary environmental phenol biomarker concentrations have reported low to 
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moderate reproducibility, with lowest reproducibility typically reported for bisphenol A 
(Braun and others 2011; Engel and others 2014; Meeker and others 2013; Philippat and 
others 2013; Teitelbaum and others 2008). For phenols with ubiquitous exposure sources, a 
single spot urine sample may be adequate to classify exposure over a period of months 
(Calafat and others 2015). Nevertheless, exposure misclassification may have biased results 
toward the null. Further, the critical window during pregnancy for an effect of phenols on 
mechanisms related to adipogenesis and metabolic homeostasis is unknown. We measured 
phenol biomarkers in urine collected during the third trimester, which may be an important 
developmental window given rapid fetal growth and adipogenesis during this time (Dietz 
1994). Early pregnancy or postnatal exposures may also play a role and were not 
characterized in the current study. Although there was considerable loss to follow-up in this 
cohort, we conducted a state-of-the-art sensitivity analysis to examine the potential for bias 
from outcomes missing not at random and did not observe evidence of selection bias. 
However, loss to follow-up did result in a smaller sample size that reduced our ability to 
detect potential associations.
Availability of bioelectrical impedance analysis estimates of body composition is an 
important strength of our study compared to reports that rely on body mass index as a proxy 
for excess body fat. Body mass index does not differentiate lean and fat mass (Freedman and 
Sherry 2009), leading to outcome misclassification and reduced ability to detect subtle 
changes in fat accumulation. There is known variation in fat mass within a given body mass 
index and vice versa, particularly in children (Ellis 2001; Wright and others 2008). For 
example, a high body mass index can be achieved through greater muscle or bone mass 
rather than fat mass (Lohman and Going 2006). Although the Tanita equations we used to 
estimate fat mass are not validated for children aged <7 years, we previously compared the 
Tanita output to two alternative equations validated for estimating fat mass from 
bioelectrical impedance measures in children and concluded the Tanita-read values 
outperformed other equations (Buckley and others 2015). Other strengths of our study 
include 1) prospective evaluation of prenatal exposures, 2) repeated measures of childhood 
body fat, 3) adjustment for maternal sociodemographic and anthropometric characteristics, 
and 4) use of a Bayesian modeling framework to account for missing exposure, covariate, 
and outcome data.
In summary, we did not observe associations of third trimester maternal urinary 
environmental phenol concentrations with childhood fat mass at ages 4 to 9 years, though we 
cannot rule out potential bias toward the null due to exposure misclassification. In this first 
study of prenatal benzophenone-3 exposure and body size to include females, we observed a 
weak association of benzophenone-3 with lower body fat among girls but not boys. This 
finding requires replication in larger human cohorts as well as elucidation through animal 
studies designed to assess the potential of benzophenone-3 to act as an antiobesogen.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Quantified four phenol biomarkers in third trimester maternal spot urine 
samples.
• Assessed percent fat mass at multiple follow-up visits between ages 4 and 9 
years.
• After adjustment, no association with 2,5-dichlorophenol, bisphenol A, or 
triclosan.
• Benzophenone-3 was weakly associated with lower percent fat mass in girls 
only.
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Table 1
Characteristics of participants in the birth cohort and study sample, Mount Sinai Children’s Environmental 
Health Study [n (%)]
Characteristic Birth cohort Study sample
Total (N) 404 173
Race/ethnicity
 Non-Hispanic white 86 (21.3) 32 (18.5)
 Non-Hispanic black 112 (27.7) 48 (27.8)
 Hispanic or other 206 (51.0) 93 (53.8)
Maternal age at delivery (years)
 < 20 142 (35.2) 52 (30.1)
 20–24 132 (32.7) 59 (34.1)
 25–29 44 (10.9) 26 (15.0)
 ≥ 30 86 (21.3) 36 (20.8)
Maternal education (≥ college degree) 100 (24.8) 38 (22.0)
Maternal work status during pregnancy (employed) 235 (58.2) 104 (60.1)
Maternal smoking during pregnancy 67 (16.6) 29 (16.8)
Maternal pre-pregnancy BMI (kg/m2)
 < 18.5 82 (20.3) 10 (5.8)
 18.5-24.9 215 (53.2) 106 (61.3)
 25-29.9 72 (17.8) 42 (24.3)
 ≥ 30 35 (8.7) 15 (8.7)
Maternal height (m) (mean and SD) 1.63 (0.07) 1.62 (0.10)
Adequacy of gestational weight gain
Characteristic Birth cohort Study sample
 Less than recommended 44 (12.3) 14 (9.1)
 Recommended 75 (21.0) 39 (25.3)
 More than recommended 238 (66.7) 101 (65.6)
 Missing 47 19
Year of maternal urine collection
 1998 84 (21.9) 32 (18.5)
 1999 127 (33.2) 54 (31.2)
 2000 134 (35.0) 68 (39.3)
 2001 35 (9.1) 18 (10.4)
 2002 3 (0.8) 1 (0.6)
 Urine not collected 21 0
Child's sex (male) 222 (55.0) 94 (54.3)
Breastfed
 Ever 206 (63.0) 108 (62.8)
 Never 121 (37.0) 64 (37.2)
 Missing 77 1
Physical activity at follow-upa
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Characteristic Birth cohort Study sample
 Inactive 97 (57.1)
 Active most of the time 73 (42.9)
 Missing 3
Body mass index (BMI); standard deviation (SD)
aProportion classified as inactive at any follow-up visit.
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Table 3
Percent fat mass distributions in the Mount Sinai Children’s Environmental Health Study, 2004 – 2008
Outcome/visita
Overall Girls Boys
n Mean ± SD n Mean ± SD n Mean ± SD
Percent fat massb
 All visits 351 18.3 ± 8.26 170 17.7 ± 9.74 181 19.0 ± 6.53
 Visit 1 95 15.1 ± 7.40 47 12.6 ± 8.84 48 17.5 ± 4.61
 Visit 2 112 17.5 ± 7.01 55 16.7 ± 8.48 57 18.2 ± 5.19
 Visit 3 144 21.2 ± 8.78 68 21.9 ± 9.54 76 20.5 ± 8.04
Standard deviation (SD)
aMean age in years ± SD for visits 1, 2, and 3 were 4.9 ± 0.4, 6.2 ± 0.2, 7.8 ± 0.8, respectively.
bPercent fat mass estimated using bioelectrical impedance analysis (Tanita TBF-300).
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Table 4
Adjusted associations between third trimester maternal urinary phenol biomarker concentrations and percent 
fat mass among children aged 4 to 9 years, Mount Sinai Children’s Environmental Health Study (173 children 
with 351 follow-up visits)
Biomarker Overall Girls Boys
Unadjusteda
 2,5-dichlorophenol 1.24 (0.08, 2.40) 2.08 (0.46, 3.69) 0.46 (−1.11, 2.04) *
 Benzophenone-3 −1.13 (−2.24, 0.00) −1.77 (−3.36, −0.20) −0.53 (−2.05, 1.00)
 Bisphenol A 0.80 (−0.26, 1.85) 1.08 (−0.36, 2.51) 0.50 (−0.94, 1.96)
 Triclosan 0.66 (−0.33, 1.65) 0.42 (−0.87, 1.72) 0.93 (−0.52, 2.35)
Adjustedb
 2,5-dichlorophenol 0.46 (−0.80, 1.73) 0.69 (−1.02, 2.40) 0.24 (−1.40, 1.89)
 Benzophenone-3 −0.83 (−1.95, 0.29) −1.51 (−3.06, 0.01)
−0.20 (−1.69, 1.26) *
 Bisphenol A 0.46 (−0.60, 1.51) 0.30 (−1.09, 1.68) 0.63 (−0.84, 2.09)
 Triclosan 0.42 (−0.52, 1.36) 0.24 (−1.01, 1.48) 0.66 (−0.77, 2.08)
Beta coefficients (95% credible intervals) per standard deviation increase in natural log creatinine-standardized phenol biomarker concentration 
estimated in linear mixed effects regression models. Sex-specific estimates were estimated by including a product term between the phenol 
biomarker and child’s sex.
*Met criteria for heterogeneity by child’s sex (i.e., 80% credible interval for phenol by sex product term excluded the null value).
aAdjusted only for natural log creatinine.
bAdjusted for natural log creatinine and urine collection date; maternal race/ethnicity, age, education, work status, smoking during pregnancy, 
height, pre-pregnancy body mass index, and adequacy of gestational weight gain; prenatal summed di-(2-ethylhexyl) phthalate metabolite 
concentrations; breastfeeding; months of age and physical activity at follow-up; and, for overall models, child’s sex.
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